Sentinel 3.0 Platform BPA
Type: Forecast
Overview
Description
IT Acquisition: Sentinel 3.0. The goal of the next Sentinel 3.0 System contract is to continue meeting or exceeding the legislative requirements, promote program efficiency, support the anticipated needs of each of the distinctive underlying Sentinel 3.0 components (e.g., Active Postmarket Risk Identification and Analysis (ARIA) system), and ensure sufficient flexibility to address. Although not within the scope of this IDIQ, FDA envisions that other government organizations (e.g., Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH)) may also have an interest in leveraging the Sentinel 3.0 System (i.e., Data Platform and the data provided by the participating data contractors) to support the advancement of public health.
Est. Value
Min: $100,000,000
Max: $None
Max: $None
Est. Award Date
27-Feb
Future Opp
Source Est. Solicitation Date
26-Aug
NAICS
Set Aside
To be determined
Forecast Type
Recompete
Place of Performance
USA
Forecast Source
Department of Health and Human Services
Food and Drug Administration is forecasted to issue a recompete procurement for Sentinel 3.0 Platform BPA around 27-Feb.
Agency
Source Level 1 Agency
Department of Health and Human Services
Source Level 2 Agency
FDA
Contacts
Point of Contact
ODT Acquisition Liaison
Point of Contact Email
Small Business Offices
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/6/26
Date Modified
11/7/26
Additional Notes
Program Office: 75F401; Contracting Office: 75F402; Vehicle type is identified as BPA in the title and IDIQ in the description.